You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《異動股》博安生物(06955.HK)創上市新低後倒升最多59% 交投放量
阿思達克 09-19 11:15
自綠葉製藥(02186.HK)分拆的內地綜合性生物製藥商博安生物(06955.HK)連續兩日震盪上行,今日(19日)平開報15.08元後,初段曾跌見13元創上市低,隨後轉勢倒升最多59.2%,最高見24元創半年高。現報19.96元,續升32.36%,成交續激增至100.72萬股,涉資2,070.28萬元。現市值逾100億元。 綠葉製藥七連升後,現回吐2%,報3.39元,成交788.9萬元;市值逾127.5億元。 公司去年底以每股19.8元上市,當時料淨集資約1.53億元。其上月底披露6月底止中期業績,營業額2.61億元人民幣(下同),按年升18.4%。虧損收窄至1.2億元,上年同期蝕1.53億元;每股虧損0.23元。不派息。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account